However, it is of concern that our current work is focused on the preventive effect of GSK3β inhibition on acute liver failure, although some studies have shown that TDZD-8 has some preventive and therapeutic value in ischemia–reperfusion injury [43]. The gene discussed is GSK3B; the disease is acute liver failure.